Literature DB >> 26846927

Incidence of Radiologically Isolated Syndrome: A Population-Based Study.

Y Forslin1, T Granberg2, A Antwan Jumah3, S Shams4, P Aspelin4, M Kristoffersen-Wiberg4, J Martola4, S Fredrikson5.   

Abstract

BACKGROUND AND
PURPOSE: Incidental MR imaging findings resembling MS in asymptomatic individuals, fulfilling the Okuda criteria, are termed "radiologically isolated syndrome." Those with radiologically isolated syndrome are at high risk of their condition converting to MS. The epidemiology of radiologically isolated syndrome remains largely unknown, and there are no population-based studies, to our knowledge. Our aim was to study the population-based incidence of radiologically isolated syndrome in a high-incidence region for MS and to evaluate the effect on radiologically isolated syndrome incidence when revising the original radiologically isolated syndrome criteria by using the latest radiologic classification for dissemination in space.
MATERIALS AND METHODS: All 2272 brain MR imaging scans in 1907 persons obtained during 2013 in the Swedish county of Västmanland, with a population of 259,000 inhabitants, were blindly evaluated by a senior radiologist and a senior neuroradiologist. The Okuda criteria for radiologically isolated syndrome were applied by using both the Barkhof and Swanton classifications for dissemination in space. Assessments of clinical data were performed by a radiology resident and a senior neurologist.
RESULTS: The cumulative incidence of radiologically isolated syndrome was 2 patients (0.1%), equaling an incidence rate of 0.8 cases per 100,000 person-years, in a region with an incidence rate of MS of 10.2 cases per 100,000 person-years. There was no difference in the radiologically isolated syndrome incidence rate when applying a modified version of the Okuda criteria by using the newer Swanton classification for dissemination in space.
CONCLUSIONS: Radiologically isolated syndrome is uncommon in a high-incidence region for MS. Adapting the Okuda criteria to use the dissemination in space-Swanton classification may be feasible. Future studies on radiologically isolated syndrome may benefit from a collaborative approach to ensure adequate numbers of participants.
© 2016 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2016        PMID: 26846927      PMCID: PMC7963557          DOI: 10.3174/ajnr.A4660

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  30 in total

Review 1.  Radiologically isolated syndrome--incidental magnetic resonance imaging findings suggestive of multiple sclerosis, a systematic review.

Authors:  Tobias Granberg; Juha Martola; Maria Kristoffersen-Wiberg; Peter Aspelin; Sten Fredrikson
Journal:  Mult Scler       Date:  2012-07-03       Impact factor: 6.312

Review 2.  MS in Asian countries.

Authors:  M Wasay; I A Khatri; B Khealani; M Sheerani
Journal:  Int MS J       Date:  2006-05

3.  Association of MRI metrics and cognitive impairment in radiologically isolated syndromes.

Authors:  M P Amato; B Hakiki; B Goretti; F Rossi; M L Stromillo; A Giorgio; M Roscio; A Ghezzi; L Guidi; M L Bartolozzi; E Portaccio; N De Stefano
Journal:  Neurology       Date:  2012-01-18       Impact factor: 9.910

4.  A clinical patho-anatomical study of clinically silent multiple sclerosis.

Authors:  T Engell
Journal:  Acta Neurol Scand       Date:  1989-05       Impact factor: 3.209

5.  Cognitive function in radiologically isolated syndrome.

Authors:  Christine Lebrun; Frederic Blanc; David Brassat; Hélène Zephir; Jerome de Seze
Journal:  Mult Scler       Date:  2010-07-07       Impact factor: 6.312

6.  Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients.

Authors:  Christine Lebrun; Caroline Bensa; Marc Debouverie; Sandrine Wiertlevski; David Brassat; Jerome de Seze; Lucien Rumbach; Jean Pelletier; Pierre Labauge; Bruno Brochet; Ayman Tourbah; Pierre Clavelou
Journal:  Arch Neurol       Date:  2009-07

7.  Prevalence of brain magnetic resonance imaging meeting Barkhof and McDonald criteria for dissemination in space among headache patients.

Authors:  Syrone Liu; Jonathan Kullnat; Dennis Bourdette; Jack Simon; Dale F Kraemer; Charles Murchison; Bronwyn E Hamilton
Journal:  Mult Scler       Date:  2013-02-04       Impact factor: 6.312

8.  Multiple sclerosis in Pakistan.

Authors:  M Wasay; S Ali; I A Khatri; A Hassan; M Asif; N Zakiullah; A Ahmed; A Malik; B Khealani; A Haq; S Fredrikson
Journal:  Mult Scler       Date:  2007-02-09       Impact factor: 6.312

9.  Improving the characterization of radiologically isolated syndrome suggestive of multiple sclerosis.

Authors:  Nicola De Stefano; Maria Laura Stromillo; Francesca Rossi; Marco Battaglini; Antonio Giorgio; Emilio Portaccio; Bahia Hakiki; Gianmichele Malentacchi; Claudio Gasperini; Mario Santangelo; Maria Letizia Bartolozzi; Maria Pia Sormani; Antonio Federico; Maria Pia Amato
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

10.  MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study.

Authors:  Josephine K Swanton; Alex Rovira; Mar Tintore; Daniel R Altmann; Frederik Barkhof; Massimo Filippi; Elena Huerga; Katherine A Miszkiel; Gordon T Plant; Chris Polman; Marco Rovaris; Alan J Thompson; Xavier Montalban; David H Miller
Journal:  Lancet Neurol       Date:  2007-08       Impact factor: 44.182

View more
  8 in total

1.  Structural and functional MRI correlates of T2 hyperintensities of brain white matter in young neurologically asymptomatic adults.

Authors:  Miloš Keřkovský; Jakub Stulík; Marek Dostál; Matyáš Kuhn; Jan Lošák; Petra Praksová; Monika Hulová; Josef Bednařík; Andrea Šprláková-Puková; Marek Mechl
Journal:  Eur Radiol       Date:  2019-05-29       Impact factor: 5.315

2.  Does the radiologically isolated syndrome exist? A dual-task cost pilot study.

Authors:  Vincenzo Dattola; Anna Lisa Logiudice; Lilla Bonanno; Fausto Famà; Demetrio Milardi; Gaetana Chillemi; Giangaetano D'Aleo; Silvia Marino; Rocco Salvatore Calabrò; Margherita Russo
Journal:  Neurol Sci       Date:  2017-08-22       Impact factor: 3.307

Review 3.  [Diagnosis of multiple sclerosis: revision of the McDonald criteria 2017].

Authors:  O Aktas; M P Wattjes; M Stangel; H-P Hartung
Journal:  Nervenarzt       Date:  2018-12       Impact factor: 1.214

Review 4.  Radiologically isolated syndrome: from biological bases to practical management.

Authors:  Andres G Barboza; Edgar Carnero Contentti; Maria Celeste Curbelo; Mario Javier Halfon; Juan Ignacio Rojas; Berenice A Silva; Vladimiro Sinay; Santiago Tizio; Maria Celica Ysrraelit; Ricardo Alonso
Journal:  Neurol Sci       Date:  2021-01-25       Impact factor: 3.307

5.  The Central Vein Sign in Radiologically Isolated Syndrome.

Authors:  S Suthiphosuwan; P Sati; M Guenette; X Montalban; D S Reich; A Bharatha; J Oh
Journal:  AJNR Am J Neuroradiol       Date:  2019-04-18       Impact factor: 3.825

Review 6.  Radiologically Isolated Syndrome: A Review for Neuroradiologists.

Authors:  M Hosseiny; S D Newsome; D M Yousem
Journal:  AJNR Am J Neuroradiol       Date:  2020-08-06       Impact factor: 3.825

Review 7.  Secondary Prevention in Radiologically Isolated Syndromes and Prodromal Stages of Multiple Sclerosis.

Authors:  Maria Pia Amato; Nicola De Stefano; Matilde Inglese; Emanuele Morena; Giovanni Ristori; Marco Salvetti; Maria Trojano
Journal:  Front Neurol       Date:  2022-03-14       Impact factor: 4.003

8.  Prevalence, Severity, and Clinical Management of Brain Incidental Findings in Healthy Young Adults: MRi-Share Cross-Sectional Study.

Authors:  Aïcha Soumaré; Naka Beguedou; Alexandre Laurent; Bruno Brochet; Constance Bordes; Sandy Mournet; Emmanuel Mellet; Edwige Pereira; Clothilde Pollet; Morgane Lachaize; Marie Mougin; Ami Tsuchida; Hugues Loiseau; Thomas Tourdias; Christophe Tzourio; Bernard Mazoyer; Stéphanie Debette
Journal:  Front Neurol       Date:  2021-05-20       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.